TP53 and cancer: We determined the prevalence of oncogenic/likely oncogenic mutations among 30 cancer-related genes, including TP53, PIK3CA, PTEN, EGFR, SMAD4, and TERT promoter (TERTp) genes, where mutations in TP53, receptor tyrosine kinase (RTK) pathway genes, and TERTp demonstrated prognostic relevance [10,13].